16-51141264-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_002968.3(SALL1):c.958C>T(p.Gln320*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002968.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Townes-Brocks syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Townes-Brocks syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002968.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SALL1 | NM_002968.3 | MANE Select | c.958C>T | p.Gln320* | stop_gained | Exon 2 of 3 | NP_002959.2 | ||
| SALL1 | NM_001127892.2 | c.667C>T | p.Gln223* | stop_gained | Exon 2 of 3 | NP_001121364.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SALL1 | ENST00000251020.9 | TSL:1 MANE Select | c.958C>T | p.Gln320* | stop_gained | Exon 2 of 3 | ENSP00000251020.4 | ||
| SALL1 | ENST00000566102.1 | TSL:1 | c.77-3712C>T | intron | N/A | ENSP00000455582.1 | |||
| SALL1 | ENST00000440970.6 | TSL:5 | c.958C>T | p.Gln320* | stop_gained | Exon 3 of 4 | ENSP00000407914.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 53
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Townes syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant is expected to result in a truncated protein lacking all  double zinc finger (DZF) domains which are critical for SALL1 protein function (PMID: 16088922, 9973281) This variant has not been reported in the literature in individuals with SALL1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the SALL1 gene (p.Gln320*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 1005 amino acids (~76%) of the SALL1 protein.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at